wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem

Subskrypcja najnowszych ofert pracy

Nasi partnerzy:


Boston Children's Hospital to Tap IBM Watson to Tackle Rare Pediatric Diseases 2015.11.15

Boston, USA - November 10, 2015 - IBM (NYSE: IBM) and Boston Children's Hospital today announced that they intend to collaborate to apply IBM's Watson cognitive platform to help clinicians identify possible options for the diagnosis and treatment of rare pediatric diseases. The news was unveiled at the Global Pediatric Innovation Summit + Awards (#PedInno15). In an initial project focused on kidney disease, Watson will analyze the massive volumes of scientific literature and clinical databases on the Watson Health Cloud to match genetic mutations to diseases and help uncover insights that could help clinicians identify treatment options. At Boston Children's, investigators at The Manton Center for Orphan Disease Research are focused on diagnosing children with a wide variety of rare genetic conditions.

Dr. Christopher Walsh, Chief of Genetics at Boston Children's Hospital explores the IBM Watson for Genomics Dashboard.
IBM and Boston Children's Hospital announced a new collaboration that aims to help clinicians identify potential diagnosis and treatment options for children with rare diseases using genomic data and cognitive technology.
Photo courtesy of IBM / Boston Children's Hospital

Boston, USA - November 10, 2015

• Collaboration Aims to Help Clinicians Identify Possible Diagnosis and Treatment Options Using Genomic Data and Cognitive Technology, Starting with Kidney Disease

IBM (NYSE: IBM) and Boston Children’s Hospital today announced that they intend to collaborate to apply IBM’s Watson cognitive platform to help clinicians identify possible options for the diagnosis and treatment of rare pediatric diseases.

The news was unveiled at the Global Pediatric Innovation Summit + Awards (#PedInno15).

Photo courtesy of IBM
In an initial project focused on kidney disease, Watson will analyze the massive volumes of scientific literature and clinical databases on the Watson Health Cloud to match genetic mutations to diseases and help uncover insights that could help clinicians identify treatment options.

Today about 1 in 10 Americans suffer from a rare disease, and half of these patients are children, according to the Global Genes Project. There are some 7,000 known rare disorders ranging from benign abnormalities to life-threatening disease.

Deborah DiSanzo, general manager, IBM Watson Health.
Photo courtesy of IBM
Many affected children pass away before a diagnosis can be made, leaving families to grieve without knowing what might have been done to help them, or how to avoid additional brothers or sisters being affected.

At Boston Children’s, investigators at The Manton Center for Orphan Disease Research are focused on diagnosing children with a wide variety of rare genetic conditions.

The Technology & Innovation Development Office (TIDO) is the industry gateway to Boston Children's Hospital researchers, and biomedical innovations and technologies in all major biomedical markets for both pediatric and adult applications.
Photo courtesy of Boston Children's Hospital
While strides have been made, the interpretation of sequencing results can be a labor-intensive process, presenting an overload of information whose analysis may not always yield a definitive causative variant.

In the new collaboration, Watson will be trained in nephrology by reading related medical literature and aggregating information on causative mutations for steroid-resistant nephrotic syndrome (SRNS), a rare genetic form of kidney disease.

Innovation is at the core of Boston Children’s Hospital.
Since its inception in the summer of 2010, Boston Children’s Innovation Acceleration Program (IAP) has been a mentor and guide for the hospital’s best and brightest innovators.
Formed upon the recommendations of the Task Force for Clinical Innovation (a 14-member cross section of hospital leadership) and with the support of executive leadership, the IAP has defined the path for innovation at all levels of the institution.
Photo courtesy of Boston Children's Hospital
Then, experts at Boston Children’s Hospital intend to feed genomic sequencing data from retrospective patients into Watson to further train the system.

The goal is to create a cognitive system that can help clinicians interpret a child’s genome sequencing data, compare this with medical literature and quickly identify anomalies that may be responsible for the unexplained symptoms.

Christopher Walsh, MD, PhD, director of the Division of Genetics and Genomics at Boston Children’s Hospital.
Photo courtesy of Boston Children's Hospital
“Coping with an undiagnosed illness is a tremendous challenge for many of the children and families we see,”
said Christopher Walsh, MD, PhD, director of the Division of Genetics and Genomics at Boston Children’s Hospital.
“Watson can help us ensure we’ve left no stone unturned in our search to diagnose and cure these rare diseases so we can uncover all relevant insights from the patient’s clinical history, DNA data, supporting evidence and population health data.”

Christopher Walsh, MD, PhD, director of the Division of Genetics and Genomics at Boston Children’s Hospital works with the Watson for Genomics system.
Photo courtesy of IBM / Boston Children's Hospital
Even with a diagnosis, effective treatment for rare conditions can be elusive.

For example, SRNS are usually unresponsive to immunosuppressive therapy, and often must go on chronic dialysis or wait for a kidney transplant - only to have their disease frequently recur in the new organ.

Deborah DiSanzo, general manager, IBM Watson Health.
Photo courtesy of IBM
“One of Watson’s talents is quickly finding hidden insights and connecting patterns in massive volumes of data,”
said Deborah DiSanzo, general manager, IBM Watson Health.
“Rare disease diagnosis is a fitting application for cognitive technology that can assimilate different types and sources of data to help doctors solve medical mysteries. For the kids and their families suffering without a diagnosis, our goal is to team with the world’s leading experts to create a cognitive tool that will make it easier for doctors to find the needle in the haystack, uncovering all relevant medical advances to support effective care for the child.”

Friedhelm Hildebrandt, MD, chief of the Division of Nephrology at Boston Children’s and Claritas Genomics.
As Hildebrandt shows here, the ADCK4 protein localizes in the mitochondria (left image) and, when absent, causes zebrafish to show symptoms mirroring the human disease (shown at right).
Photo courtesy of Boston Children's Hospital
The kidney project will be done in collaboration with Friedhelm Hildebrandt, MD, chief of the Division of Nephrology at Boston Children’s and Claritas Genomics.

Following its successful completion, Boston Children’s plans to expand the effort into undiagnosed neurologic disorders and other disease areas studied by The Manton Center, improving diagnostic and treatment services for patients nationwide.

Boston Children’s Hospital is part of the Undiagnosed Diseases Network, a NIH program that aims to solve medical mysteries by integrating genetics, genomics, and rare disease expertise.

Boston Children’s was also the incubator behind Claritas Genomics, a genetic diagnostic laboratory that offers genetic testing and develops new diagnostic tests and solutions, and organizer of the CLARITY Undiagnosed Challenge, a crowd sourcing competition seeking best practices in clinical genomics.

The results and winner of the Challenge will be announced at the Boston Children’s Hospital Global Pediatric Innovation Summit on November 10.

Boston Children’s Hospital announced today at the Global Pediatric Innovation Summit + Awards the results of its international CLARITY Undiagnosed Challenge.
In this genomics competition, 26 registered teams from seven countries sought to interpret DNA sequences and provide information to five families about conditions that had eluded diagnosis despite multiple doctor visits, tests and genetic studies.
Representatives from the winning team, Nationwide Children's Hospital (Columbus, OH), was awarded USD 25,000 - receive their prize.
Pictured from left to right: Catherine Brownstein, Donald Corsmeier, Peter White, Alan Beggs.
Photo courtesy of Boston Children's Hospital
IBM has been developing Watson’s ability to analyze genomic data in collaboration with leading cancer centers around the world.

The system is currently being used at 16 cancer institutes to analyze and translate genomic data to help oncologists uncover personalized treatment options.

The new project with Boston Children’s represents the first time this technology will be applied to help clinicians efficiently identify possible options for rare disease diagnosis and treatment.

The Manton Center for Orphan Disease Research at Boston Children's Hospital (BCH) was created to develop new methods for understanding, diagnosing and treating unusual diseases and to apply this knowledge to make fundamental scientific advances with broad implications for human health.
Jorg Richter visits the Manton Center after biking coast to coast across the United States for rare disease awareness.
Photo courtesy of Boston Children's Hospital
IBM and Boston Children’s are also working together to build OPENPediatrics, an online platform designed to bring life-saving medical knowledge to pediatric caregivers worldwide.

In September, the two organizations announced they will integrate Watson’s deep and iterative question and answer capability to enhance and scale the OPENPediatrics initiative.

Learn more about this story at

About Boston Children’s Hospital

Boston Children’s Hospital is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869.

More than 1,100 scientists, including seven members of the National Academy of Sciences, 11 members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Boston Children’s research community.

Founded as a 20-bed hospital for children, Boston Children’s today is a 397-bed comprehensive center for pediatric and adolescent health care.

Boston Children’s is also the pediatric teaching affiliate of Harvard Medical School.

For more, visit our Vector and Thriving blogs and follow us on our social media channels:
Facebook and YouTube.

About IBM Watson Health

Watson is the first commercially available cognitive computing capability representing a new era in computing.

The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers.

Watson continuously learns, gaining in value and knowledge over time, from previous interactions.

In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform.

The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing insights from the massive amount of personal health data being created and shared daily.

The Watson Health Cloud allows this information to be de-identified, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

For more information on IBM Watson,
visit: ibm.com/watson.

For more information on IBM Watson Health,
visit: ibm.com/watsonhealth

Check out the IBM Watson press kit at:

Join the conversation at #ibmwatson and #watsonhealth.

Follow Watson on Facebook and see Watson on YouTube and Flickr.

Contacts information

Christine Douglass
IBM Media Relations
1 (415) 535-4479

Kristen Dattoli
Boston Children’s Hospital Media Relations
1 (617) 919-3141

Source: IBM


ASTROMAN Magazine - 2015.10.24

Wywiad z Prof. Romualdem Krajewskim, Prezydentem Europejskiej Unii Lekarzy Specjalistów UEMS na kolejną kadencję w latach 2016-2019


ASTROMAN Magazine - 2015.08.29

IBM and GENCI Team to Drive Supercomputing Closer to Exascale


ASTROMAN Magazine - 2015.08.09

IBM: Watson to Gain Ability to "See" with Planned USD1 Billion Acquisition of Merge Healthcare


ASTROMAN Magazine - 2015.07.26

Siemens Computed Tomography: 40 Years at the Cutting Edge of Technological Development


ASTROMAN Magazine - 2015.07.11

IBM Research Alliance Produces Industry's First 7nm Node Test Chips


ASTROMAN Magazine - 2015.06.27

IBM Research: Internet of Things Turning New York's Lake George into "World's Smartest Lake”


ASTROMAN Magazine - 2015.06.20

Philips and Westchester Medical Center Health Network announce USD 500 million, multi-year enterprise partnership to transform patient care


ASTROMAN Magazine - 2015.05.31

Doctor Evidence Brings Valuable Health Data to IBM Watson Ecosystem


ASTROMAN Magazine - 2015.05.02

Japan Post Group, IBM and Apple Deliver iPads and Custom Apps to Connect Elderly in Japan to Services, Family and Community


ASTROMAN Magazine - 2015.03.22

IBM Invests in Modernizing Medicine to Accelerate Adoption of Watson Technologies in Healthcare


ASTROMAN Magazine - 2015.02.28

Medtronic Acquires Advanced Uro-Solutions. Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference


ASTROMAN Magazine - 2015.02.22

IBM Studio Opens in London to Transform the Client Experience


ASTROMAN Magazine - 2015.02.04

World Cancer Day: The Road Ahead for Cervical Cancer Screening


ASTROMAN Magazine - 2015.01.19

IBM Launches z13 Mainframe - Most Powerful and Secure System Ever Built


ASTROMAN Magazine - 2014.12.24

IBM Named a Worldwide Leader in IDC MarketScape for Mobile Application Development and Testing Consulting Services


ASTROMAN Magazine - 2014.12.21

Philips to acquire Volcano to expand global leadership position in image-guided therapy market for USD 1.2 billion


ASTROMAN Magazine - 2014.12.20

ElectRx Has the Nerve to Envision Revolutionary Therapies for Self-Healing


ASTROMAN Magazine - 2014.11.22

Poland's NCBJ thermal-to-14 MeV neutron converter is a sole device of its kind operated in the world


ASTROMAN Magazine - 2014.11.10

Siemens to sell hearing aid business to EQT and Struengmann family for EUR 2.15 Billion


ASTROMAN Magazine - 2014.08.30

IBM Watson Ushers in a New Era of Data-Driven Discoveries


ASTROMAN Magazine - 2014.06.20

Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock


ASTROMAN Magazine - 2014.06.08

Fujitsu World Tour 2014 w Warszawie czyli Fujitsu buduje hiperpołączony świat


ASTROMAN Magazine - 2013.12.15

Boston Dynamics: Changing Your Idea of  What Robots Can Do


ASTROMAN Magazine - 2013.11.16

IBM Watson's Next Venture: Fueling New Era of Cognitive Apps Built in the Cloud by Developers


ASTROMAN Magazine - 2013.10.06

Philips collaborates with Accenture to create first proof of concept for delivering vital patient data via Google Glass


ASTROMAN Magazine - 2013.09.08

Philips presents latest 'digital' consumer innovations at IFA in Berlin


ASTROMAN Magazine - 2013.09.01

Philips showcases innovations in cardiology at European Society of Cardiology Congress 2013


ASTROMAN Magazine - 2013.09.01

Fujitsu Develops World's First Homomorphic Encryption Technology that Enables Statistical Calculations and Biometric Authentication


ASTROMAN Magazine - 2013.08.16

HealthInterlink Joins Alcatel-Lucent's ng Connect Program for Beacon Clinical Care Access


ASTROMAN Magazine – 2013.08.10

Fujitsu and Microsoft Japan to Equip Meiji Yasuda Life Insurance's 30,000 Advisors


ASTROMAN Magazine – 2013.05.19

Fujitsu Semiconductor Develops World's First 360° Wraparound View System with Approaching Object Detection


ASTROMAN Magazine – 2012.08.26

New era for interventional cardiologists as GE Healthcare's Discovery is CE Marked


ASTROMAN Magazine – 2012.06.08

GE Healthcare and Philips Healthcare Commend FCC Rule for Wireless Medical Sensor Technologies


ASTROMAN Magazine – 2012.06.07

Microsoft and General Electric Healthcare Complete Joint Venture Agreement for new company Caradigm


ASTROMAN Magazine – 2012.04.22

GE Healthcare to Develop Next Generation Compact Cyclotron and PET Tracer System for Global Markets


ASTROMAN Magazine – 2012.04.14

Dolby and Philips Unveil 3D HD Format Capable of Bringing Full HD 3D to Glasses-Free 3D Devices


ASTROMAN Magazine – 2012.03.18

Philips and the World Association of Sleep Medicine join together to raise global awareness of the importance of sleep


ASTROMAN Magazine – 2012.03.03

IBM Forms Watson Healthcare Advisory Board


ASTROMAN Magazine – 2012.02.12

Philips and Catharina Hospital collaborate to highlight innovation in heart rhythm disorder treatment


ASTROMAN Magazine – 2011.12.26

Philips and VU University Medical Center Amsterdam sign agreement for PET/MR scanner


ASTROMAN Magazine – 2011.12.11

GE, Microsoft to Launch Joint Venture Aimed at Global Healthcare System Transformation


ASTROMAN Magazine – 2011.12.04

GE Healthcare Taps Global Industry Leader to Head Magnetic Resonance Business


ASTROMAN Magazine – 2011.10.04

GE Healthcare Spotlights its Commitment to Advancing Cancer Care at ASTRO 2011


ASTROMAN Magazine – 2011.09.18

GE Healthcare to Invest $1 Billion in New Oncology Solutions


ASTROMAN Magazine – 2011.07.11

GE Healthcare Wins Design Excellence Awards for Magnetic Resonance Imaging


ASTROMAN Magazine – 2011.06.04

GE Healthcare Opens Life Sciences Demonstration Laboratory in Stockholm, Sweden


ASTROMAN Magazine – 2011.02.23

Philips and Microsoft Collaborate to Streamline Radiology Workflow and Processes


ASTROMAN Magazine – 2011.02.20

IBM to Collaborate with Nuance to Apply IBM's "Watson" Analytics Technology to Healthcare


ASTROMAN Magazine - 2011.01.23

Siemens Healthcare unveils the world's first integrated whole-body molecular MR system available for clinical use


Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, PhD.

wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
Selena Group - increase of net profit in the very first quarter of 2019
IBM: Major Ocean Carriers CMA CGM and MSC to Join TradeLens Blockchain-Enabled Digital Shipping Platform
deepsense.ai: A comprehensive guide to demand forecasting with machine learning
Wojciech Kostrzewa nowym Prezesem Polskiej Rady Biznesu
Uroczysta Gala Nagrody Polskiej Rady Biznesu 2019
SpaceX launched 60 Starlink satellites from Space Launch Complex 40 at Cape Canaveral Air Force Station, Florida
ImpactCEE 2019: Danubia NanoTech wins the PowerUp! Grand Final 2019
Panasonic Launches Comprehensive Showroom for Residential Materials such as Kitchens in India
HPE to acquire supercomputing leader Cray. Combined Company Will Drive Next Generation of High Performance Computing
Lilium reveals new air taxi as it celebrates maiden flight
SIEMENS "Local" data processing - Edge Computing simplifies data processing in intelligent factory Amberg
Anno Borkowsky appointed to the LANXESS Board of Management
Application phase for the seventh BASF and Volkswagen "Science Award Electrochemistry" has begun
Selena Group: Tytan mounting foams of the new generation speed up the installation of doors and windows
Prestiżowe tytuły "Inwestor bez granic" przyznane podczas Europejskiego Kongresu Gospodarczego
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2020. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.